跳至主要内容
临床试验/IRCT20210118050069N1
IRCT20210118050069N1招募中2 期

Safety and efficacy of magnesium sulfate as an adjuvant to peribulbar block for glaucoma surgery in morbidly obese patients: A randomized clinical trial

Research Institute of Ophthalmology0 个研究点目标入组 46 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Glaucoma surgery patients
  • ASA physical status I, II, or III
  • Aged from 18 to 70 years
  • Axial length 20-28 mm
  • Body mass index 30-55 kg/m2

排除标准

  • Coagulopathy or use of anticoagulant drugs
  • Previous allergy or adverse reaction to the used drugs
  • Patients with conditions preventing them from lying flat or staying still during operation as skeletal problems, orthopneic patients, or those with uncontrolled tremors (as Parkinsonism)

研究者

发起方
Research Institute of Ophthalmology

相似试验

Magnesium sulfate as an adjuvant to peribulbar block... | 临床试验